Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model
Jana Desloovere, Paul Boon, Lars Emil Larsen, et al.
Neurotherapeutics (2021) Vol. 19, Iss. 1, pp. 342-351
Open Access | Times Cited: 20

Showing 20 citing articles:

Acetylcholine receptor based chemogenetics engineered for neuronal inhibition and seizure control assessed in mice
Quynh-Anh Nguyen, Peter Klein, Cheng Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination
Helen Bachmann, Boris Vandemoortele, Vanessa Vermeirssen, et al.
Brain stimulation (2024) Vol. 17, Iss. 3, pp. 575-587
Open Access | Times Cited: 9
Mesial Temporal Lobe Epilepsy
Matthew C. Walker, Maria Thom, Umesh Vivekananda
Oxford University Press eBooks (2025), pp. 895-920
Closed Access | Times Cited: 1
Increased Dentate Gyrus Excitability in the Intrahippocampal Kainic Acid Mouse Model for Temporal Lobe Epilepsy
Marijke Vergaelen, Simona Manzella, Kristl Vonck, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 660-660
Open Access | Times Cited: 7
Applications of chemogenetics in non-human primates
Jessica Raper, Adriana Galván
Current Opinion in Pharmacology (2022) Vol. 64, pp. 102204-102204
Open Access | Times Cited: 25
A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
Kate A. Lawson, Christina M. Ruiz, Stephen V. Mahler
Psychopharmacology (2023) Vol. 240, Iss. 10, pp. 2101-2110
Open Access | Times Cited: 12
Effects of chemogenetic virus injection and clozapine administration in spinal cord injury
Ji Hyeon Kim, Scott N. Hwang, Hye Yeong Lee, et al.
Neurotherapeutics (2025), pp. e00547-e00547
Open Access
Chemogenetic activation of the diaphragm after spinal cord injury in rats
Ethan S. Benevides, Sabhya Rana, David D. Fuller
Respiratory Physiology & Neurobiology (2025), pp. 104421-104421
Closed Access
Recent progress and challenges in gene therapy for pharmacoresistant focal epilepsy
Dimitri M. Kullmann
Revue Neurologique (2025)
Closed Access
Unraveling the Neural Circuits: Techniques, Opportunities and Challenges in Epilepsy Research
Wenjie Xiao, Peile Li, Fujiao Kong, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Animal Models of Febrile Seizures: Limitations and Recent Advances in the Field
Alexandra V. Griflyuk, Tatyana Y. Postnikova, Aleksey V. Zaitsev
Cells (2024) Vol. 13, Iss. 22, pp. 1895-1895
Open Access | Times Cited: 3
Grafted hPSC-derived GABA-ergic interneurons regulate seizures and specific cognitive function in temporal lobe epilepsy
Dinesh Upadhya, Sahithi Attaluri, Yan Liu, et al.
npj Regenerative Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Activation of Basal Forebrain Astrocytes Induces Wakefulness without Compensatory Changes in Sleep Drive
Ashley M. Ingiosi, Christopher R. Hayworth, Marcos G. Frank
Journal of Neuroscience (2023) Vol. 43, Iss. 32, pp. 5792-5809
Open Access | Times Cited: 7
Chemogenetic Signaling in Space and Time: Considerations for Designing Neuroscience Experiments Using DREADDs
P. J. Clark, Zachary D. Brodnik, Rodrigo A. España
The Neuroscientist (2022) Vol. 30, Iss. 3, pp. 328-346
Closed Access | Times Cited: 8
Seizing Control of Neuronal Activity: Chemogenetic Applications in Epilepsy
Patrick A. Forcelli
Epiliepsy currents/Epilepsy currents (2022) Vol. 22, Iss. 5, pp. 303-308
Open Access | Times Cited: 7
A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
Kate A. Lawson, Christina M. Ruiz, Stephen V. Mahler
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
High dose administration of DREADD agonist JHU37160 produces increases in anxiety-like behavior in male rats
J. Savage, Elizabeth M. Avegno
Behavioural Brain Research (2023) Vol. 452, pp. 114553-114553
Open Access | Times Cited: 2
Advanced approaches for selective investigation of neuronal function and circuitry: The future of developing novel therapeutic strategies in neuropharmacology?
Srđan Joksimović, Sonja Lj. Joksimovic
Arhiv za farmaciju (2023) Vol. 73, Iss. 2, pp. 109-125
Open Access | Times Cited: 1
Chemogenetics with PSAM4-GlyR decreases excitability and epileptiform activity in epileptic hippocampus
Ana Gonzalez‐Ramos, Fredrik Berglind, Jan Kudláček, et al.
Gene Therapy (2024)
Open Access
Chemogenetic silencing of the subiculum blocks acute chronic temporal lobe epilepsy
Jianbang Lin, Jing Liu, Qi Zhang, et al.
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access
Page 1

Scroll to top